MoneyWorks4Me

Vivanza Biosciences - Quaterly Results

26 Oct 2023 Evaluate
The total revenue stands at Rs. 38.72 millions for the September 2023 quarter. The mentioned figure indicates an increase of about 271.24% as against Rs. 10.43 millions during  the year-ago period.A humble growth in net profit of 24.67% reported in the quarter ended September 2023 to Rs. 1.87  millions from Rs. 1.50 millions.Operating profit for the quarter ended September 2023 rose to 2.96 millions as compared to 2.53 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 38.72 10.43 271.24 87.48 33.87 158.28 142.07 91.48 55.30
Other Income 0.52 2.41 -78.42 0.66 2.52 -73.81 3.87 8.28 -53.26
PBIDT 2.96 2.53 17.00 7.33 4.11 78.35 11.08 8.77 26.34
Interest 1.08 1.02 5.88 2.19 2.02 8.42 4.18 4.06 2.96
PBDT 1.88 1.51 24.50 5.14 2.09 145.93 6.90 4.71 46.50
Depreciation 0.01 0.01 0.00 0.02 0.02 0.00 0.03 0.07 -57.14
PBT 1.87 1.50 24.67 5.12 2.07 147.34 6.87 4.64 48.06
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.18 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00
PAT 1.87 1.50 24.67 5.12 2.07 147.34 5.69 4.64 22.63
Equity 40.00 40.00 0.00 40.00 40.00 0.00 40.00 40.00 0.00
PBIDTM(%) 7.64 24.26 -68.48 8.38 12.13 -30.95 7.80 9.59 -18.65
Peers